Compare LEDS & HSCS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | LEDS | HSCS |
|---|---|---|
| Founded | 2005 | 2007 |
| Country | Taiwan | United States |
| Employees | N/A | N/A |
| Industry | Semiconductors | Medical Specialities |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 18.8M | 15.8M |
| IPO Year | 2010 | 2022 |
| Metric | LEDS | HSCS |
|---|---|---|
| Price | $1.88 | $1.77 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 10.5K | ★ 75.5K |
| Earning Date | 12-01-2026 | 12-14-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 53.12 | 50.84 |
| EPS | ★ 0.02 | N/A |
| Revenue | ★ $43,009,000.00 | $4,319.00 |
| Revenue This Year | N/A | $295.93 |
| Revenue Next Year | N/A | $18,321.05 |
| P/E Ratio | $92.00 | ★ N/A |
| Revenue Growth | ★ 729.81 | N/A |
| 52 Week Low | $1.01 | $1.63 |
| 52 Week High | $3.62 | $5.25 |
| Indicator | LEDS | HSCS |
|---|---|---|
| Relative Strength Index (RSI) | 40.19 | 27.72 |
| Support Level | $1.85 | N/A |
| Resistance Level | $2.52 | $2.18 |
| Average True Range (ATR) | 0.24 | 0.31 |
| MACD | -0.04 | -0.06 |
| Stochastic Oscillator | 18.06 | 0.00 |
SemiLEDs Corp develops, manufactures, and sells light-emitting diode chips and LED components. The company's products include LED Chips, LED Components, and Lighting Products. Its products are used for general lighting applications, including street lights and commercial, industrial, system, and residential lighting; specialty industrial applications, such as ultraviolet, or Ultraviolet, curing of polymers, LED light therapy in medical/cosmetic applications, counterfeit detection, LED lighting for horticulture applications, architectural lighting and entertainment lighting. Substantial revenue is generated from the sale of LED components products. Geographically, it derives a majority of its revenue from Japan.
HeartSciences Inc is an artificial intelligence (AI)-powered medical technology company focused on transforming ECGs/EKGs to save lives through earlier detection of heart disease. Its objective is to improve healthcare by making it a far more valuable cardiac screening tool, particularly in frontline or point-of-care clinical settings. It is developing a suite of AI-ECG diagnostic solutions for use in any healthcare setting, either via the MyoVista Insights cloud-platform using one of the millions of ECG devices currently in clinical use or via the MyoVista wavECG Device.